Coronation Fund Managers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.4M Buy
96,798
+22,421
+30% +$8.31M 1.43% 18
2026
Q1
$21.8M Sell
74,377
-84,872
-53% -$27.9M 0.99% 22
2025
Q4
$55.8M Buy
159,249
+31,754
+25% +$10.7M 2.5% 11
2025
Q3
$41.2M Sell
127,495
-9,872
-7% -$3.07M 2.15% 13
2025
Q2
$53.4M Buy
+137,367
New +$55.3M 2.9% 11
2024
Q4
Sell
-90,098
Closed -$46.9M 51
2024
Q3
$46.9M Buy
90,098
+4,406
+5% +$2.35M 2.6% 12
2024
Q2
$46.4M Sell
85,692
-103,500
-55% -$54.7M 2.68% 13
2024
Q1
$98.1M Buy
189,192
+20,290
+12% +$10.1M 2.67% 7
2023
Q4
$79.6M Buy
168,902
+20,084
+13% +$9.29M 2.22% 14
2023
Q3
$64.8M Buy
148,818
+59,856
+67% +$27.1M 1.95% 12
2023
Q2
$39.5M Buy
88,962
+63,163
+245% +$29.1M 1.06% 38
2023
Q1
$11.9M Buy
25,799
+7,498
+41% +$3.57M 0.32% 65
2022
Q4
$9.39M Sell
18,301
-561
-3% -$285K 0.26% 79
2022
Q3
$8.57M Sell
18,862
-393
-2% -$188K 0.46% 52
2022
Q2
$9.29M Sell
19,255
-24,477
-56% -$12.1M 0.52% 52
2022
Q1
$21.5M Sell
43,732
-33,004
-43% -$15.1M 0.84% 32
2021
Q4
$35.6M Buy
76,736
+4,803
+7% +$2.02M 1.31% 23
2021
Q3
$26.8M Hold
71,933
1.01% 27
2021
Q2
$27.5M Buy
71,933
+5,749
+9% +$2.2M 0.86% 26
2021
Q1
$23.8M Sell
66,184
-1,945
-3% -$625K 0.78% 31
2020
Q4
$21.9M Sell
68,129
-2,497
-4% -$766K 0.7% 33
2020
Q3
$19M Sell
70,626
-6,585
-9% -$1.77M 0.69% 30
2020
Q2
$20.3M Buy
77,211
+3,253
+4% +$868K 0.77% 27
2020
Q1
$16.8M Sell
73,958
-1,293
-2% -$352K 0.8% 23
2019
Q4
$22.7M Buy
75,251
+4,168
+6% +$1.15M 0.77% 24
2019
Q3
$17.1M Buy
71,083
+16,489
+30% +$4.52M 0.64% 31
2019
Q2
$15.4M Sell
54,594
-4,667
-8% -$1.27M 0.56% 34
2019
Q1
$17M Buy
59,261
+20,434
+53% +$5.91M 0.63% 29
2018
Q4
$10.2M Sell
38,827
-9,093
-19% -$2.5M 0.49% 36
2018
Q3
$13.1M Sell
47,920
-15,104
-24% -$3.92M 0.57% 38
2018
Q2
$15M Sell
63,024
-26,134
-29% -$6.05M 0.58% 41
2018
Q1
$19.6M Sell
89,158
-4,277
-5% -$1M 0.78% 31
2017
Q4
$21M Sell
93,435
-1,044
-1% -$222K 0.66% 38
2017
Q3
$17.9M Sell
94,479
-3,028
-3% -$576K 0.54% 39
2017
Q2
$18.3M Buy
+97,507
New +$17.5M 0.57% 41

Other funds holding ELV

Coronation Fund Managers's ELV Position: Q2 2026 in Review

Coronation Fund Managers increased its Elevance Health (ELV) stake by 30% in Q2 2026, buying an estimated $8.31M and bringing the position to 96,798 shares worth $37.4M. The position accounts for 1.43% of the portfolio, ranked #18.

Coronation Fund Managers first reported a position in ELV in Q2 2017 and has held it in 35 quarters since. The position peaked at $98.1M in Q1 2024. 534 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Coronation Fund Managers held 96,798 shares of Elevance Health worth $37.4M as of Q2 2026.
  • Coronation Fund Managers bought 22,421 Elevance Health shares in Q2 2026, an estimated $8.31M.
  • Elevance Health made up 1.43% of Coronation Fund Managers's portfolio in Q2 2026, its #18 holding.
  • Coronation Fund Managers first reported a position in Elevance Health in Q2 2017 and has held it in 35 quarters since.
  • Coronation Fund Managers's Elevance Health position peaked at $98.1M in Q1 2024.
  • 534 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Coronation Fund Managers's 13F filing for Q2 2026, filed 27 Jul 2026.